Introducing new technology safely.
OBJECTIVE
This report considers the introduction of new technology and the implications for patient safety.


RESULTS
A distinction is made between 'conceptually' new and 'contextually' new technology. The life cycle of technology from development to routine use is discussed and the key role for regulation, health technology assessment, clinical engineering and surveillance in this life cycle considered. The limitations of each of these disciplines are also discussed. Special consideration is given to the needs of developing countries. Case study examples of particular challenges in the safe introduction of technology are presented.
Mytton
Oliver T
OT
WHO Patient Safety, Department of Health, London, UK. oliver.mytton@dh.gsi.gov.uk
Velazquez
Adriana
A
Banken
Reiner
R
Mathew
Joseph L
JL
Ikonen
Tuija S
TS
Taylor
Kevin
K
Painter
Frank
F
Jean-Baptiste
Rachel
R
Poon
Albert
A
Ruelas
Enrique
E
D001698:Biomedical Engineering; D020811:Biomedical Technology / Q000331:legislation & jurisprudence; D003906:Developing Countries; D017598:Efficiency, Organizational; D033161:Government Regulation; D006801:Humans; D013677:Medical Laboratory Science; D019982:Organizational Case Studies; D061214:Patient Safety; D011050:Policy Making; D013673:Technology Assessment, Biomedical / Q000331:legislation & jurisprudence